Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Conjunctivitis

• Evaluation of Miebo (Perfluorohexyloctane) Eyedrops in Habitual Contact Lens Wearers
• A Study of TL-925 for the Treatment of Allergic Conjunctivitis
• A Study of MDI-1228_mesylate Ophthalmic Solution in Healthy Adults
• Efficacy and Safety Evaluation of Tavilermide Ophthalmic Solution for the Treatment of Dry Eye
• Trial to Evaluate the Efficacy and Safety of IVIEW-1201 in Acute Bacterial Conjunctivitis
• Evaluation of Brimonidine Tartrate/Ketotifen Fumarate Combination in Adults With Seasonal Allergic Conjunctivitis
• Evaluation of Brimonidine Tartrate/Ketotifen Fumarate Combination for the Treatment of Allergic Conjunctivitis
• Clinical Trial to Evaluate Safety and Efficacy of Cell Therapy in Patients With Cicatricial Conjuntivitis.
• Efficacy of the Anti-Bet v 1 Monoclonal Antibodies (Given Subcutaneously) to Reduce Allergic Rhinitis and Conjunctivitis Symptoms and Skin Test Reactivity Upon Exposure to Birch Allergen in Adult Participants
• Clinical Course and Treatment of Ligneous Conjunctivitis in Children With Plasminogen Deficiency
• The Efficacy Of SCH1 In The Treatment Of Acute Infectious Conjunctivitis
• A Study Comparing the Efficacy of Pataday® Once Daily Relief Extra Strength to Flonase® Allergy Relief in Subjects With Allergic Conjunctivitis
• A Study Comparing the Efficacy of Pataday® Once Daily Relief Extra Strength to Claritin® Tablets 24-Hour in Subjects With Allergic Conjunctivitis
• Baricitinib for the Treatment of Ocular Mucous Membrane Pemphigoid
• The INVIGORATE 2 Trial: A Randomized, Double-masked, Crossover Design, Phase 3 Clinical Trial to Assess the Efficacy and Safety of Subjects With Seasonal Allergic Conjunctivitis
• Documentation of Efficacy of Intralymphatic Allergen Immunotherapy
• Safety and Efficacy of Pilocarpine Ophthalmic Topical Cream (4%, 6%, 8%)
• Subcutaneous Immunotherapy With BM41 in Patients With Allergic Rhino-conjunctivitis Caused by Birch Pollen
• A Study in Adults With Grass Pollen-induced Rhinoconjunctivitis
• The Effect of Upneeq (Oxymetazoline Hydrochloride 0.1%) on Eyelid Position, Eye Redness, and Eye Appearance
• Study to Assess the Safety, Tolerability and Efficacy of Bilastine Ophthalmic Solution 0.6% in Children
• Efficacy and Toxicity of Bepotastine 1,5% PF vs Olopatadine 0,2% With BAK on Allergic Conjunctivitis Treatment
• Study to Assess the Efficacy of Anti-Bet v 1 Monoclonal Antibodies in Adults to Reduce Symptoms of Seasonal Allergic Rhinitis
• DEXTENZA Therapy for Treatment of Allergic Conjunctivitis
• Safety and Efficacy of VSJ-110 in the Treatment of Allergic Conjunctivitis in Adults With a History of Ocular Allergies
• Therapeutic Effect of Tacrosolv in Patients With Allergic Rhinoconjunctivitis
• Safety and Efficacy of Intracanalicular Dexamethasone Compared to Loteprednol Etabonate in Patients With Keratoconus
• The INVIGORATE Trial: A Clinical Trial to Assess the Efficacy and Safety of Subjects With Seasonal Allergic Conjunctivitis.
• A Study Evaluating the Safety and Efficacy of OTX-DP for the Treatment of Allergic Conjunctivitis
• To Study Efficacy and Safety of Tobradex Eye Drop Suspension vs Tobramycin/Dexamethasone Ophthalmic Suspension
• Treatment With Allogeneic Adipose-derived Mesenchymal Stem Cells in Patients With Aqueous Deficient Dry Eye Disease
• Manuka Eye Droops for Treatment of Allergy
• OKG-0301 for the Treatment of Acute Adenoviral Conjunctivitis
• Demonstration of Equivalence and Early Onset of a Novel Anti-allergic Nasal Spray Compared to Marketed Nasal Spray
• Trial to Evaluate the Efficacy and Safety of IVIEW-1201 in Acute Viral Conjunctivitis
• A Methodology Development Clinical Trial of Reproxalap in Subjects With Seasonal Allergic Conjunctivitis Using the Environmental Exposure Chamber
• Safety and Tolerability of PRO-143 Ophthalmic Solution in Healthy Volunteers.
• Efficacy of the Ophthalmic Pazufloxacin 0.6% for Bacterial Conjunctivitis, Compared to Gatifloxacin 0.3%.
• A Methodology Development Environmental Clinical Trial of Reproxalap in Subjects With Seasonal Allergic Conjunctivitis
• Safety and Efficacy of KPI-121 in Subjects With DED
• Safety and Tolerability of the PRO-174 Versus Sophixín Ofteno®, on the Ocular Surface of Healthy Subjects
• ALLEVIATE Trial - A Phase 3 Trial in Subjects With Allergic Conjunctivitis
• A Single-Center Evaluation of the Relative Efficacy of EM-100 Compared to Zaditor® (Ketotifen Fumarate Ophthalmic Solution 0.035%) and Vehicle
• A Study Evaluating Bilastine Ophthalmic Solution 0.6% in the Conjunctival Allergen Challenge (Ora-CAC®) Model
• A Study of AK002 in Patients With Atopic Keratoconjunctivitis, Vernal Keratoconjunctivitis, and Perennial Allergic Conjunctivitis
• Evaluation of Subcutaneous Immunotherapy Towards Pollen in Children
• Effectiveness of PR013 Topical Ophthalmic Drops Compared to Vehicle for the Treatment of Allergic Conjunctivitis
• Study Evaluating the Efficacy and Safety of PRT-2761 for the Treatment of Acute and Chronic Allergic Conjunctivitis
• A Single-Center, Phase 2 Study Evaluating Bilastine Ophthalmic Solution in the CAC® Model
• Clinical Evaluation of Hylo-Dual Versus Patanol in Children With Seasonal Allergic Conjunctivitis
• A Study of ADX-102 in Subjects With Allergic Conjunctivitis
• Efficacy and Safety of Iota-Carrageenan Eye Drops (NCX-4240)
• Treatment of Bacterial Conjunctivitis With SHP640 Compared to PVP-Iodine and Placebo
• Treatment of Adenoviral Conjunctivitis With SHP640 Compared to Placebo
• Treatment of Adenoviral Conjunctivitis With SHP640 Compared to Povidone-iodine (PVP-I) and Placebo
• OTX-15-002: A Phase 3 Study Evaluating the Safety and Efficacy of OTX-DP for the Treatment of Chronic Allergic Conjunctivitis
• Safety and Efficacy of PRO-157 vs Moxifloxacin vs Gatifloxacin in Patients With Bacterial Conjunctivitis (Pazufloxacin)
• Evaluation of the Effectiveness of ST266 Ophthalmic Drops Compared to Placebo to Treat Allergic Conjunctivitis
• Efficacy and Safety of Grass-SPIRE Registration Study
• Efficacy of Co-administration of Bilastine and Montelukast in Patients With SARC and Asthma
• A Safety and Activity Study of NS2 in Subjects With Allergic Conjunctivitis
• Safety and Efficacy of Lastacaft® for the Prevention of Itching Associated With Allergic Conjunctivitis in Korea
• A Multi-Center Environmental Study for the Treatment of Moderate to Severe Ocular Allergic Conjunctivitis
• A Dose-response Evaluation of the SQ Tree SLIT-tablet Using an Environmental Exposure Chamber
• Reducing Adenoviral Patient Infected Days
• OTX-14-007: A Phase 3 Study Evaluating the Safety and Efficacy of OTX-DP for the Treatment of Chronic Allergic Conjunctivitis
• Safety and Efficacy of Vancomycin Ophthalmic Ointment in Patients With Moderate to Severe Bacterial Conjunctivitis
• Olopatadine Hydrochloride Ophthalmic Solution Study in Chinese Subjects
• A Single-Center Evaluation of the Anti-Inflammatory Effects of Lastacaft as Measured by In-Vivo Confocal Microscopy
• Observational Study of Oralair® in Children 5-9 Years With Grass-pollen-induced Allergic Rhinitis With/Without Conjunctivitis
• Compare Dose Regimens of AllerT, in Adults With Allergic Rhino-Conjunctivitis to Birch Pollen Studied in EEC
• Effectiveness of Olopatadine HCl Ophthalmic Solution for the Treatment of Allergic Conjunctivitis in Japan
• SUBLIVAC FIX Birch Phase III Short-term Efficacy
• Evaluation of the Efficacy and Safety of AVANZ® Phleum Pratense in Grass Pollen-induced Allergic Rhinitis During Controlled Exposure in an Environmental Challenge Chamber
• AGN-229666 Ophthalmic Solution in Japanese Patients With Allergic Conjunctivitis
• Phase II HDM-SPIRE Safety and Efficacy Study
• A Multi-Center Study Evaluating the Safety of AC-170 0.24%
• A Single Center Study for the Treatment of Moderate to Severe Allergic Conjunctivitis (EBI-005-AC-1)
• AGN-229666 Ophthalmic Solution for the Treatment of Seasonal or Perennial Allergic Conjunctivitis
• Safety and Efficacy Study of AL-53817 and AL-78843 Ophthalmic Solutions for Allergic Conjunctivitis
• OTX-14-001: A Phase 2 Study Evaluating the Safety and Efficacy of OTX-DP for the Treatment of Chronic Allergic Conjunctivitis
• Safety and Efficacy of Relestat Ophthalmic Solution 0.05% for Allergic Conjunctivitis in Korea
• Therapeutic Efficacy of APD-209 Eye Drops in Treatment of Epidemic Keratoconjunctivitis (EKC)
• Paediatric Safety Study in Cat-PAD
• Efficacy and Safety of Intraseasonal Specific Immunotherapy With Depiquick® Birch
• A Multi-Center, Evaluation of the Onset and Duration of Action of AC-170 0.24% Compared to Vehicle
• The Effect of Pollen Season on Subcutaneous Allergen Immunotherapy Reactions
• Efficacy and Safety of Auriclosene (NVC-422) in the Treatment of Bacterial Conjunctivitis
• Hydrocortisone Ophthalmic Ointment 0.5% for Treatment of Allergic Conjunctivitis
• Ocular Allergy Treatment Practical Impact Trial
• Artificial Tears Versus Preservative Free Ketorolac Trometamol 0.45% for Acute Viral Conjunctivitis
• AGN-229666 for the Treatment of Allergic Conjunctivitis
• Efficacy and Safety of an Ophthalmic Solution in Patients With Allergic Conjunctivitis
• Clinical and Microbial Efficacy of Besifloxacin Ophthalmic Suspension, 0.6% in the Treatment of Bacterial Conjunctivitis
• A Trial Evaluating Tolerability of Grazax Treatment in Combination With Antihistamine
• Safety Clinical Trial With Depigopid 50% Grasses/50% Olea Europaea(2000DPP/ml) or Depigoid 50% Grasses/50% Parietaria Judaica(2000DPP/ml).
• A Study to Evaluate the Efficacy of Lastacaft® Compared to Pataday™ and Placebo in Patients With Acute Allergic Conjunctivitis
• Evaluation of Prednisolone in a Modified Conjunctival Allergen Challenge Model
• Antibiotic Steroid Combination Compared With Individual Administration in the in the Treatment of Ocular Inflammation and Infection
• A Six-Week Safety Study of an Investigational Ophthalmic Solution
• Confocal Analysis of Corneal Structures of Symptomatic Allergic Conjunctivitis Patients
• A Single-Center,Evaluation of the Onset and Duration of Action of AC-170 0.24% Compared to Vehicle
• Clinical Efficacy of PRO-118 Compared With Olopatadine Hydrochloride Ophthalmic Solution in Allergic Conjunctivitis
• Evaluation of the Onset and Duration of Action of RX-10045 in Allergic Conjunctivitis
• SUBLIVAC FIX Birch Dose Tolerability/Dose Range Finding
• Phase III Cat-PAD Study
• Evaluate the Use of Ganciclovir Gel 0.3% for the Treatment of Conjunctivitis Caused by Adenovirus
• An Evaluation of the Safety and Efficacy of Moxifloxacin Ophthalmic Solution 0.5% ((VIGAMOX®) Versus Ofloxacin Ophthalmic Solution 0.3% in the Treatment of Bacterial Conjunctivitis in Chinese Patients
• Non-Pharmaceutical Treatment of Seasonal Allergic Conjunctivitis
• An Evaluation of the Onset and Duration of Action of AKF-1 Ophthalmic Solution in Treating Acute Allergic Conjunctivitis
• A Multi-Center Study Evaluating the Onset and Duration of Action of AC-170 0.24% Compared to Vehicle in the Conjunctival Allergen Challenge (CAC)
• Efficacy and Safety of PRO-118 Ophthalmic Solution in Allergic Conjunctivitis
• Evaluation of the Efficacy of Topical Ophthalmic Steroids in a Modified Conjunctival Allergen Challenge (CAC) Model
• A Placebo Controlled Comparison of Topical Zirgan Versus Genteal Gel for the Treatment of Adenovirus Conjunctivitis
• Efficacy and Safety of NVC-422 in the Treatment of Adenoviral Conjunctivitis
• Dose Range Finding Study With rBet v1-FV - in Adult Patients With Birch Pollen-Allergic Seasonal Rhinoconjunctivitis
• A Trial of Topical Dexamethasone Versus Artificial Tears for Treatment of Viral Conjunctivitis
• Efficacy and Safety of AL-4943A Ophthalmic Solution in Patients With Allergic Conjunctivitis Using the Conjunctival Allergen Challenge (CAC) Model
• FST-100 in the Treatment of Acute Adenoviral Conjunctivitis
• A Study to Evaluate the Duration of LASTACAFT® in Acute Allergic Conjunctivitis
• Vitamin D and Grass Pollen Specific Immunotherapy
• FST-100 in the Treatment of Acute Viral Conjunctivitis
• Bepreve vs. Alrex in Subjects With Moderate to Severe Allergic Conjunctivitis
• An Allergen BioCube (ABC) Study Evaluating the Efficacy of Fluticasone Propionate Nasal Spray Compared to Placebo
• A Study to Evaluate the Safety and Efficacy of Lotemax Ophthalmic Suspension 0.5%
• Alrex® Versus Patanol in the Treatment of Seasonal Allergic Conjunctivitis(SAC)
• Tolerability of Grazax in Patients With Hayfever in Real Life Settings
• Comparison of Tolerability Between Two Allergy Drops
• A Long-term Study of DE-114 Ophthalmic Solution in Patients With Allergic Conjunctivitis
• Study of DE-114 Ophthalmic Solution in Patients With Allergic Conjunctivitis
• 2nd Pivotal Study rPhleum - Adults and Adolescents With Rhinoconjunctivitis +/-Controlled Asthma
• Ganciclovir 0,15% Ophthalmic Gel in the Treatment of Adenovirus Keratoconjuntivitis
• The Effect of BEPREVE 1.5% on Tear Film Osmolarity and Tear Film Lipid Layer
• Comparison of the Efficacy and Tolerability of T1210 and Olopatadine Hydrochloride 0.1% in the Treatment of Seasonal Allergic Conjunctivitis
• Use of BEPREVE (Bepotastine Besilate Ophthalmic Solution) 1.5% for Allergic Conjunctivitis and Contact Lenses
• Efficacy of AC-170 for the Treatment of Allergic Conjunctivitis in the Conjunctival Allergen Challenge (CAC) Model
• Besifloxacin Ophthalmic Suspension Verses Gatifloxacin Ophthalmic Solution in Neonates With Bacterial Conjunctivitis
• Safety and Comfort of AL-4943A Ophthalmic Solution
• Effect of Different Concentrations of SPARC1102 on Allergic Conjunctivitis
• Patient Perception Study for AL-4943A
• Mapracorat Ophthalmic Formulation in Subjects With Allergic Conjunctivitis
• A Study to Evaluate the Safety and Efficacy of the QLT Proprietary Olopatadine-PPDS in Subjects With Seasonal Allergic Conjunctivitis to Ragweed in an Environmental Exposure Chamber Model.
• Assessment of Alcon's Ocular Image Quantification System
• A Single-Center, Randomized, Double-Masked, Placebo and Active Controlled, Dose-Ranging Evaluation of the Duration of Action of Brimonidine Tartrate Ophthalmic Solution in the Control of Ocular Redness Induced by Conjunctival Allergen Challenge (CAC
• A Study of Patient Perception and Quality of Life Associated With the Use of Olopatadine 0.2% in Subjects With Allergic Conjunctivitis
• Safety and Efficacy of Olopatadine Hydrochloride/Ketorolac Tromethamine Ophthalmic Solution Compared With Olopatadine Hydrochloride Ophthalmic Solution in Patients With Seasonal Allergic Conjunctivitis
• Safety and Efficacy of AL-15469A 0.5% / AL-6515 0.3% Ophthalmic Suspension for Treatment of Bacterial Conjunctivitis
• Effectiveness Comparison Between the Drugs TOBRACORT® and TOBRADEX® in Reducing the Signs and Symptoms of Acute Bacterial Conjunctivitis
• Efficacy Maxinom® And Maxitrol® in Reducing The Signs And Symptoms Of Acute Bacterial Conjunctivitis
• A Four Week, Open-Label Study of Azithromycin Ophthalmic Solution, 1% (P08641)
• Evaluation of the Effect and Tolerance of Preservative Free NAAGA on the Inflammatory Component and Symptoms of Dry Eye Syndrome in Allergic Conjunctivitis Patients
• Treatment of Epidemic Keratoconjunctivitis With 2% Povidone-iodine
• The Effect of Oral Azithromycin in the Treatment of Chlamydial Conjunctivitis
• Safety of Besivance™ (Besifloxacin Ophthalmic Suspension) 0.6% Compared to Vehicle
• Safety and Efficacy of Bepotastine Besilate Ophthalmic Solution in Seasonal Allergic Conjunctivitis Patients
• Patient Perceptions and Quality of Life Associated With the Use of Olapatadine 0.2% for the Treatment of Allergic Conjunctivitis
• Study Evaluating the Safety of KetoNaph Ophthalmic Solution in Healthy Volunteers
• Clinical Efficacy and Safety of T1225 Versus Tobramycin 0.3 % Eye Drops in the Treatment of Purulent Bacterial Conjunctivitis of Children.
• Efficacy of AC-150 for the Treatment of Allergic Conjunctivitis in the Enviro-CAC™ Model
• Study Evaluating the Efficacy of Administration of Cyclosporine (Low Dose and High Dose) and Prednisolone Acetate Compared to Its Components and Vehicle in Patients With Allergic Conjunctivitis
• Assessing the Efficacy of Maxidex® and Patanol® for the Treatment of Allergic Conjunctivitis
• Clinical Evaluation of 0.1% Olopatadine Hydrochloride Ophthalmic Solution in Pediatric Patients
• Loteprednol Ophthalmic Base Compared to Loteprednol Ophthalmic Suspension vs Placebo in an Allergen Challenge
• Changes in Specific Immunoglobulin and Blood Basophil Activity During Subcutaneous Immunotherapy in Allergic Rhinitis
• Pharmacokinetic Study of Bilastine in Children From 2 to < 12 Years of Age With Either Allergic Rhinoconjunctivitis (AR) or Chronic Urticaria (CU)
• PURETHAL Grasses Rush Study
• An Open-Label, Long-Term Study With AL-4943A Ophthalmic Solution, 0.2% in Patients With Allergic Conjunctivitis
• Loteprednol and Tobramycin Versus Tobramycin and Dexamethasone, in the Treatment of Blepharokeratoconjunctivitis
• Immunomodulation of E.Coli Nissle 1917 in Patients With Grass Pollen Rhinoconjunctivitis
• AL-38583 Ophthalmic Solution for Allergic Conjunctivitis Associated Inflammation
• Study of Olopatadine HCl Ophthalmic Solutions Compared to Vehicle Using the Conjunctival Allergen Challenge (CAC) Model of Acute Allergic Conjunctivitis in Japanese Subjects
• Safety Study of Ragweed Allergy Immunotherapy Tablet in Subjects 50 Years of Age and Older (Study P06081)
• Study With High Dose PURETHAL Mites in Allergic Rhinitis/Rhinoconjunctivitis Patients
• Efficacy of Besifloxacin Ophthalmic Suspension in the Treatment of Bacterial Conjunctivitis
• Study of Efficacy and Safety of 300 IR Sublingual Immunotherapy (SLIT) Tablets in Adult Patients With Allergic Grass Pollen Rhinoconjunctivitis
• FST-100 Ophthalmic Suspension in Acute Adenoviral Conjunctivitis
• SUBLIVAC® Birch PROBE Study
• An Evaluation of the Efficacy and Safety of AL-46383A Ophthalmic Solution for the Treatment of Adenoviral Conjunctivitis
• Study of the Effect of Fluticasone Furoate Nasal Spray on Spring Allergy Eye Symptoms
• Safety and Efficacy Study of a Eye Drop for Eye Allergy
• Efficacy and Safety Study of Cyclosporine 0.010% to Treat Atopic Keratoconjunctivitis
• Efficacy Study to Evaluate the Effectiveness of 3 Concentrations of SAR 1118 in Allergic Conjunctivitis
• To Evaluate the Efficacy of AL-38583 in the Reduction of Tear Eosinophil Count Following Conjunctival Allergen Challenge
• Evaluation of the Safety and Efficacy of Ketotifen 4.0% Patch as Compared to Placebo Patch, Olopatadine 0.2% Ophthalmic Solution, and Artificial Tears in the Conjunctival Allergen Challenge (CAC) Model of Acute Allergic Conjunctivitis
• Evaluation of Efficacy of Coadministration of FOV1101-00 and Prednisolone Acetate in Patients With Mild Ongoing Ocular Allergic Inflammation
• Long-term Efficacy and Safety Study With Oralgen Grass Pollen
• Efficacy Investigation Study of Olopatadine Hydrochloride Ophthalmic Solution Using OHIO Chamber in Patients With Seasonal Allergic Rhinitis (SAR)
• Open Label Safety Study of a Birch Pollen Allergen Extract
• A Randomised, Double-blind, Placebo Controlled Study With Oralgen Grass Pollen Rhinoconjunctivitis
• Safety and Efficacy on Phase III Study on 300 IR SLIT to Patients Suffering From Grass Pollen Rhinoconjunctivitis
• Dose Finding Study With CYT003-QbG10 in Patients With House Dust Mite Allergy
• Study of the Progression of Bacterial Conjunctivitis Symptoms Upon Antibiotic Treatment
• Olopatadine Eye Drops and Allergy Skin Testing
• Ketotifen/Naphazoline Ophthalmic Solution in the Conjunctival Allergen Challenge Model of Acute Allergic Conjunctivitis.
• Ketotifen/Naphazoline Ophthalmic Solution in the Conjunctival Allergen Challenge Model of Allergic Conjunctivitis.
• Moxifloxacin AF Ophthalmic Solution for Treatment of Bacterial Conjunctivitis
• Comparative Study of AzaSite Plus Compared to AzaSite Alone and Dexamethasone Alone to Treat Subjects With Blepharoconjunctivitis
• Safety/Efficacy of Antibiotic Steroid Combination in Treatment of Blepharitis and/or Keratitis and/or Conjunctivitis
• Safety and Efficacy of Zylet vs Lotemax, Tobramycin and Vehicle in Pediatric Blepharoconjunctivitis
• Evaluation of the Efficacy of Topical Ophthalmic Steroids in a Modified Conjunctival Allergen Challenge (CAC) Model
• A Comparison of Olopatadine and Fluticasone in Patients With Allergic Conjunctivitis
• Clinical and Microbial Efficacy of ISV403 in Bacterial Conjunctivitis
• Effect of Olopatadine on Allergic Tear Mediators
• Efficacy and Safety Study of Bepotastine Besilate Ophthalmic Solution in Allergic Conjunctivitis
• Safety Study for Bepotastine Besilate Ophthalmic Solution in Normal Volunteers
• Moxifloxacin vs. Polytrim for Conjunctivitis
• Comparative Study of AzaSite Plus Compared to AzaSite Alone and Dexamethasone Alone to Treat Subjects With Blepharoconjunctivitis
• A Study to Investigate an Immunomodulatory Therapy in Adult Patients With Perennial Allergic Rhinoconjunctivitis
• Efficacy, Safety and PK of Once or Twice Daily Bilastine (10 or 20 mg) Compared With Placebo in the Symptomatic Treatment of SAR
• A Study to Investigate an Immunomodulatory Therapy in Adult Patients With Perennial Allergic Rhinoconjunctivitis
• Phase III, Long-Term, Open-Label, Extension Study of 0.1% Tacrolimus(FK506) Ophthalmic Suspension in Patients With Vernal Keratoconjunctivitis
• Phase III Study of 0.1% Tacrolimus(FK506) Ophthalmic Suspension in Patients With Vernal Keratoconjunctivitis
• Efficacy and Safety of Grass Pollen Sublingual Immunotherapy
• Study of Efficacy of Levofloxacin 0.5% Ophthalmic Solution Administered Three Times a Day for Bacterial Conjunctivitis
• Efficacy and Safety of Grass Sublingual Tablet in Adults (P05238 AM3)(COMPLETED)
• Montelukast as a Controller of Atopic Syndrome
• Efficacy and Safety of Grass Sublingual Tablet in Children and Adolescents (P05239 AM3)(COMPLETED)
• Study of Two Marketed Ocular Anti-Allergy Medications in Subjects With Allergic Conjunctivitis
• A Study of the Safety and Efficacy of Gatifloxacin in Patients With Bacterial Conjunctivitis
• A Study of the Safety and Efficacy of Gatifloxacin in Patients With Bacterial Conjunctivitis
• Comparison of CL Wear Between Two Allergy Drops
• A Study to Evaluate the Safety and Efficacy of Gatifloxacin for the Treatment of Bacterial Conjunctivitis
• Evaluation of Efficacy and Safety of an Anti-Allergy Drug With a Contact Lens in the Treatment of Allergic Conjunctivitis
• Topical Tacrolimus 0.03% Ointment for Intractable Allergic Conjunctivitis: An Open Label Pilot Study
• Evaluation of Efficacy and Safety of an Anti-Allergy Drug With a Contact Lens in Allergic Conjunctivitis
• Evaluation of the Onset and Duration of Action of Bepotastine Besilate Ophthalmic Solution in Acute Allergic Conjunctivitis
• Efficacy and Safety of Topical Bromfenac Ophthalmic Solution vs. Placebo in Subjects With Allergic Conjunctivitis
• Twin SUBLIVAC® Grasses Clinical Efficacy Study
• Efficacy and Safety of 300 IR Sublingual Immunotherapy (SLIT) Tablets in Children Suffering From Grass Pollen Rhinoconjunctivitis
• Systemic Pharmacokinetics of BOL-303224-A
• Mast-Cell Stabilizing Effects of Olopatadine
• A Study Of The Safety And Effectiveness Of A New Treatment For Allergic Conjunctivitis
• Safety and Efficacy of Sublingual Immunotherapy (SLIT) Tablets in Grass Pollen Rhinoconjunctivitis
• Evaluation of Efficacy of Ophthalmic Solution in Seasonal Allergic Conjunctivitis
• Efficacy and Safety of T1225 1.5% Versus Tobramycin 0.3 % in the Treatment of Purulent Bacterial Conjunctivitis
• A Study to Investigate the Safety and Efficacy of BOL-303224 in the Treatment of Bacterial Conjunctivitis
• A Study to Determine if 0.6% ISV-403 is Safe and Effective in the Treatment of Bacterial Conjunctivitis.
• AL-15469A for the Treatment of Bacterial Conjunctivitis
• AL-15469A for the Treatment of Bacterial Conjunctivitis
• Olopatadine 0.2% for the Treatment of Allergic Conjunctivitis
• Efficacy and Tolerance of Nova22007 Versus Vehicle in Patients With Vernal Keratoconjunctivitis (VKC)
• Topical Treatment of Bacterial Conjunctivitis and Its Effect on Microbial Flora
• A Study of the Effects of Desloratadine on Conjunctival Allergen Challenge-induced Ocular Signs and Symptoms (Study P04209)
• Use of Probiotic Bacteria in Prevention of Allergic Disease in Children 1999-2008
• Alleviation of Cedar Pollen Induced Allergic Symptoms by Orally Taken Superfine Beta-1,3-Glucan
• Evaluation of Efficacy of Ophthalmic Solution in Induced Allergic Conjunctivitis
• Evaluation of Efficacy of Ophthalmic Solution in Induced Acute Allergic Conjunctivitis
• Safety Study of Ophthalmic Solution in Healthy, Normal Volunteers
• Ketotifen Ophthalmic Solution With Emedastine in Patients With Seasonal Allergic Conjunctivitis
• Evaluation of Clinical and Microbial Efficacy and Safety of AzaSite Compared to Vehicle for Bacterial Conjunctivitis (C-01-401-003)
• Evaluation of Clinical and Microbial Efficacy and Safety of AzaSite Compared to Tobramycin for Bacterial Conjunctivitis (C-01-401-004)